In conclusion, the oncosuppresor functions of PHLDA1 are broadly documented in a variety of tumors such as breast cancer, neuroblastoma, cholangiocarcinoma, gastric adenocarcinoma, or melanoma. Here, PHLDA1 is linked to cholangiocarcinoma.